Gene: CCDC57
Official Full Name: coiled-coil domain containing 57provided by HGNC
Gene Summary: Involved in several processes, including G2/M transition of mitotic cell cycle; cilium assembly; and microtubule cytoskeleton organization. Located in centriolar satellite; centriole; and spindle microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19014 | CCDC57 Knockout cell line (HeLa) | Human | CCDC57 | 1:3~1:6 | Negative | Online Inquiry |
KO19015 | CCDC57 Knockout cell line (HCT 116) | Human | CCDC57 | 1:2~1:4 | Negative | Online Inquiry |
KO19016 | CCDC57 Knockout cell line (HEK293) | Human | CCDC57 | 1:3~1:6 | Negative | Online Inquiry |
KO19017 | CCDC57 Knockout cell line (A549) | Human | CCDC57 | 1:3~1:4 | Negative | Online Inquiry |
CCDC57 Gene Knockout Cell Lines are specially engineered cell lines characterized by the targeted deletion of the CCDC57 gene, which encodes a protein involved in cellular signaling pathways and structural organization. The knockout of this gene facilitates the investigation of its biological roles, mechanisms of action, and contributions to various disease states, particularly in cancer research and developmental biology.
The key function of CCDC57 Gene Knockout Cell Lines lies in their ability to provide insights into the cascading effects of CCDC57 absence on cellular behavior. Scientists utilize these cell lines to explore altered cellular processes such as proliferation, apoptosis, differentiation, and migration, offering a more comprehensive understanding of the gene's functional relevance. This model system effectively illustrates the potential pathway disruptions attributed to CCDC57, thereby revealing critical insights into disease mechanisms.
In research and clinical applications, these knockout cell lines enable a rigorous platform for drug discovery and therapeutic testing by allowing for the evaluation of treatment responses in the absence of CCDC57. Their utility can extend to studying gene-environment interactions, contributing to the development of targeted therapies that address specific molecular deficiencies related to CCDC57.
A significant advantage of using CCDC57 Gene Knockout Cell Lines is their specificity and precision, which offer an improved alternative to traditional knockdown methods, such as siRNA or shRNA approaches. Users benefit from the permanent deletion of the gene, providing stable and reproducible results that enhance the integrity of experimental outcomes.
Ultimately, the value of CCDC57 Gene Knockout Cell Lines to researchers and clinicians rests in their ability to elucidate complex biological processes and the potential for translation into cutting-edge therapeutic strategies. Our company specializes in the development of high-quality biological tools and technologies, ensuring that you have access to innovative products that propel your research and clinical applications forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.